Little, Mark P. http://orcid.org/0000-0003-0980-7567
Boerma, Marjan http://orcid.org/0000-0003-2249-5203
Bernier, Marie-Odile http://orcid.org/0000-0001-5807-4596
Azizova, Tamara V. http://orcid.org/0000-0001-6954-2674
Zablotska, Lydia B. http://orcid.org/0000-0002-0778-1108
Einstein, Andrew J. http://orcid.org/0000-0003-2583-9278
Hamada, Nobuyuki http://orcid.org/0000-0003-2518-6131
Article History
Received: 23 November 2023
Accepted: 23 April 2024
First Online: 15 June 2024
Declarations
:
: Ethical approval is not required, as all data used are in the public domain. Consent to participate in the study is not required, as all data used are in the public domain.
: Consent to publish is not required, as all data used are in the public domain.
: Andrew Einstein has received speaker fees from Ionetix; has received consulting fees from WL Gore & Associates; has received authorship fees from Wolters Kluwer Healthcare–UpToDate; and has received grants to his institution from Attralus, Canon Medical Systems, Eidos Therapeutics, GE Healthcare, Pfizer, Roche Medical Systems, WL Gore & Associates, and XyloCor Therapeutics; none of these are related to the present work. No other authors report conflicts of interest.